Journal of Cancer Research and Therapeutics Close
 

Figure 1: The effect of tested exopolysaccharide-6 and exopolysaccharide-RS on apoptotic proteins. (a) Control sample (i.e., untreated HepG2 cells). (b and c) alterations of apoptosis-related proteins in exopolysaccharide-6- and exopolysaccharide-RS-treated HepG2 cells, respectively. Protein extract (500 μg) were used for apoptosis array analysis. Array spots were visualized according to the manufacturer's instructions. The intensity of each spot was measured as described in “Materials and Methods”

Figure 1: The effect of tested exopolysaccharide-6 and exopolysaccharide-RS on apoptotic proteins. (a) Control sample (i.e., untreated HepG2 cells). (b and c) alterations of apoptosis-related proteins in exopolysaccharide-6- and exopolysaccharide-RS-treated HepG2 cells, respectively. Protein extract (500 μg) were used for apoptosis array analysis. Array spots were visualized according to the manufacturer's instructions. The intensity of each spot was measured as described in “Materials and Methods”